Stocksigma LogoStocksigma Logo

Remus Pharmaceuticals H1 FY27 Results and Interim Dividend Declaration

Remus Pharmaceuticals declared an interim dividend of Rs 1.00 per share (record date: 7th Nov'26) alongside its H1 FY27 results

Remus Pharmaceuticals H1 FY27 Results and Interim Dividend Declaration

Remus Pharmaceuticals Ltd 路 Outcome 路 03 Nov 2026, 9:29 pm

Remus Pharmaceuticals H1 FY27 Results and Interim Dividend Declaration Remus Pharmaceuticals declared an interim dividend of Rs 1.00 per share (record date: 7th Nov'26) alongside its H1 FY27 results. Consolidated revenue surged 53.45% YoY to Rs 614.12 Cr, while EBITDA grew 11.22% YoY to Rs 29.93 Cr and PAT increased 14.22% YoY to Rs 24.66 Cr. Consolidated margins absorbed setup and operating costs from newly acquired subsidiaries across Bolivia, Guatemala, and Espee GCTS. Operational milestones included securing government tenders in Bolivia and Venezuela, along with approvals for Semaglutide tablets/injections and Rotigotine patches.

Original exchange filing (PDF)

More announcements from Remus Pharmaceuticals Ltd

All Remus Pharmaceuticals Ltd announcements